Conjugate vaccines for preventing Haemophilus influenzae type b infections in children under 5 years of age

Muhammad I. Nisar, Fyezah Jehan, Yasir Shafiq, Zohra Lassi, Anita K.M. Zaidi

Research output: Contribution to journalArticlepeer-review


This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effects of conjugate Hib vaccine in preventing Hib disease or death in children under five years of age. To determine any variation in vaccine effectiveness with type of vaccine number of doses; age at first dose; known HIV infection; or in high-income and low-income countries. To determine any clinically relevant mild, moderate or serious adverse outcomes. To identify costs associated with the vaccination, adverse events and illnesses in vaccinated and unvaccinated children.

Original languageEnglish
Article numberCD010377
JournalCochrane Database of Systematic Reviews
Issue number2
Publication statusPublished or Issued - 28 Feb 2013

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this